{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "SARS-CoV-2",
      "lipid nanoparticle",
      "therapeutic interfering particles",
      "transmission",
      "variants"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "36074824",
  "DateCompleted": {
    "Year": "2022",
    "Month": "09",
    "Day": "13"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "10",
    "Day": "20"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "09",
        "Day": "08"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "e2204624119",
      "10.1073/pnas.2204624119"
    ],
    "Journal": {
      "ISSN": "1091-6490",
      "JournalIssue": {
        "Volume": "119",
        "Issue": "39",
        "PubDate": {
          "Year": "2022",
          "Month": "Sep",
          "Day": "27"
        }
      },
      "Title": "Proceedings of the National Academy of Sciences of the United States of America",
      "ISOAbbreviation": "Proc Natl Acad Sci U S A"
    },
    "ArticleTitle": "A single-administration therapeutic interfering particle reduces SARS-CoV-2 viral shedding and pathogenesis in hamsters.",
    "Pagination": {
      "StartPage": "e2204624119",
      "MedlinePgn": "e2204624119"
    },
    "Abstract": {
      "AbstractText": [
        "The high transmissibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a primary driver of the COVID-19 pandemic. While existing interventions prevent severe disease, they exhibit mixed efficacy in preventing transmission, presumably due to their limited antiviral effects in the respiratory mucosa, whereas interventions targeting the sites of viral replication might more effectively limit respiratory virus transmission. Recently, intranasally administered RNA-based therapeutic interfering particles (TIPs) were reported to suppress SARS-CoV-2 replication, exhibit a high barrier to resistance, and prevent serious disease in hamsters. Since TIPs intrinsically target the tissues with the highest viral replication burden (i.e., respiratory tissues for SARS-CoV-2), we tested the potential of TIP intervention to reduce SARS-CoV-2 shedding. Here, we report that a single, postexposure TIP dose lowers SARS-CoV-2 nasal shedding, and at 5 days postinfection, infectious virus shed is below detection limits in 4 out of 5 infected animals. Furthermore, TIPs reduce shedding of Delta variant or WA-1 from infected to uninfected hamsters. Cohoused \"contact\" animals exposed to infected, TIP-treated animals exhibited significantly lower viral loads, reduced inflammatory cytokines, no severe lung pathology, and shortened shedding duration compared to animals cohoused with untreated infected animals. TIPs may represent an effective countermeasure to limit SARS-CoV-2 transmission."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Gladstone|UCSF Center for Cell Circuitry, San Francisco, CA 94158."
          },
          {
            "Identifier": [],
            "Affiliation": "Gladstone Institute of Virology, Gladstone Institutes, San Francisco, CA 94158."
          }
        ],
        "LastName": "Chaturvedi",
        "ForeName": "Sonali",
        "Initials": "S"
      },
      {
        "Identifier": [
          "0000-0003-3240-9524"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037."
          }
        ],
        "LastName": "Beutler",
        "ForeName": "Nathan",
        "Initials": "N"
      },
      {
        "Identifier": [
          "0000-0002-5968-2312"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Gladstone|UCSF Center for Cell Circuitry, San Francisco, CA 94158."
          },
          {
            "Identifier": [],
            "Affiliation": "Gladstone Institute of Virology, Gladstone Institutes, San Francisco, CA 94158."
          }
        ],
        "LastName": "Vasen",
        "ForeName": "Gustavo",
        "Initials": "G"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Gladstone|UCSF Center for Cell Circuitry, San Francisco, CA 94158."
          },
          {
            "Identifier": [],
            "Affiliation": "Gladstone Institute of Virology, Gladstone Institutes, San Francisco, CA 94158."
          }
        ],
        "LastName": "Pablo",
        "ForeName": "Michael",
        "Initials": "M"
      },
      {
        "Identifier": [
          "0000-0001-8288-7685"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Gladstone|UCSF Center for Cell Circuitry, San Francisco, CA 94158."
          },
          {
            "Identifier": [],
            "Affiliation": "Gladstone Institute of Virology, Gladstone Institutes, San Francisco, CA 94158."
          }
        ],
        "LastName": "Chen",
        "ForeName": "Xinyue",
        "Initials": "X"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Gladstone|UCSF Center for Cell Circuitry, San Francisco, CA 94158."
          },
          {
            "Identifier": [],
            "Affiliation": "Gladstone Institute of Virology, Gladstone Institutes, San Francisco, CA 94158."
          }
        ],
        "LastName": "Calia",
        "ForeName": "Giuliana",
        "Initials": "G"
      },
      {
        "Identifier": [
          "0000-0003-1749-3772"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "VxBiosciences Inc., Berkeley, CA 94707."
          }
        ],
        "LastName": "Buie",
        "ForeName": "Lauren",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "VxBiosciences Inc., Berkeley, CA 94707."
          }
        ],
        "LastName": "Rodick",
        "ForeName": "Robert",
        "Initials": "R"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Division of Infectious Diseases, Department of Medicine, University of California San Diego, La Jolla, CA 92121."
          }
        ],
        "LastName": "Smith",
        "ForeName": "Davey",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Immunology and Microbiology, The Scripps Research Institute, La Jolla, CA 92037."
          },
          {
            "Identifier": [],
            "Affiliation": "Division of Infectious Diseases, Department of Medicine, University of California San Diego, La Jolla, CA 92121."
          }
        ],
        "LastName": "Rogers",
        "ForeName": "Thomas",
        "Initials": "T"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Gladstone|UCSF Center for Cell Circuitry, San Francisco, CA 94158."
          },
          {
            "Identifier": [],
            "Affiliation": "Gladstone Institute of Virology, Gladstone Institutes, San Francisco, CA 94158."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Biochemistry and Biophysics, University of California, San Francisco, CA 94158."
          },
          {
            "Identifier": [],
            "Affiliation": "Department of Pharmaceutical Chemistry, University of California, San Francisco, CA 94158."
          }
        ],
        "LastName": "Weinberger",
        "ForeName": "Leor S",
        "Initials": "LS"
      }
    ],
    "GrantList": [
      {
        "GrantID": "P30 AI027763",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AI169443",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't",
      "Research Support, U.S. Gov't, Non-P.H.S."
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Proc Natl Acad Sci U S A",
    "NlmUniqueID": "7505876",
    "ISSNLinking": "0027-8424"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Messenger"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Small Interfering"
    }
  ],
  "SupplMeshList": [
    "SARS-CoV-2 variants"
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "bioRxiv. 2022 Aug 11;:",
      "PMID": "35982679"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "therapy",
        "transmission"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cricetinae"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "RNA, Messenger"
    },
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "RNA, Small Interfering"
    },
    {
      "QualifierName": [
        "genetics",
        "physiology"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Virus Shedding"
    }
  ],
  "CoiStatement": "Competing interest statement: S.C., R.R., and L.S.W. are coinventors on a patent application filed for therapeutic interfering particles for SARS-CoV-2. L.S.W. is a scientific cofounder of VxBiosciences."
}